PPF biotech venture investing
We seek to support development of novel cancer therapies by providing venture capital, and if suitable, also by providing scientific and development expertise to our portfolio companies.
We are investing into biotech companies with highly innovative technologies and oncology product candidates at preclinical to clinical proof of concept stage. We review investment opportunities on global basis with prime focus on European companies.
Typically we invest jointly with other investors gaining minority ownership with capacity to make follow-on investments over several years to maximize the return. Our investment fund’s structure does not have a finite life.
We apply a state of the art scouting and evaluation process to identify attractive investment opportunities. We pledge to perform a thorough evaluation of opportunities by our internal experts with the help of external advisors.